Pericardial infusion of tissue plasminogen activator in fibropurulent pericarditis

Journal of Intensive Care Medicine

Volumn 18, Issue 1, 2003, Pages 47-51

  Reznikoff, Charles P ^a   Fish, Jeffrey T ^b   Coursin, Douglas B ^b,c  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UW CSC   (United States)

Author keywords

Pericardial effusion; Staphylococcal sepsis; Thrombolysis; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; MALE; PERICARDITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; ABSCESS; BACTEREMIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG INSTILLATION; ELECTROCARDIOGRAPHY; FIBRINOLYTIC THERAPY; FIBROSIS; INFUSION; MICROBIOLOGY; MIDDLE AGED; ORBIT DISEASE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIOTOMY; STAPHYLOCOCCUS INFECTION; TOOTH EXTRACTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WOUND DRAINAGE;

ABSCESS; BACTEREMIA; DRAINAGE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROCARDIOGRAPHY; FIBRINOLYTIC AGENTS; FIBROSIS; HUMANS; INFUSIONS, PARENTERAL; INSTILLATION, DRUG; MALE; MIDDLE AGED; ORBITAL DISEASES; PERICARDIAL EFFUSION; PERICARDIAL WINDOW TECHNIQUES; PERICARDIOCENTESIS; PERICARDITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPPURATION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TOOTH EXTRACTION; TREATMENT OUTCOME;

EID: 2942652838     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066602239124     Document Type: Article

References (14)

1. Alpert J. The importance of pharmacological profile of thrombolytic agents in clinical practice. Am J Card. 1991;68:3E-7E.
2. Twillert WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and serosanginous pleural exudations. J Clin Invest. 1949;28:173-190.
3. Goldsmith R, Sterling JA. Debridement using catalytic enzymes. Am Pract. 1951;2:858-862.
4. Wright LT, Smith DH, Rothman M, Metzger WI, Quash ET. Use of streptokinase-dornase in certain surgical conditions. J Int Coll Surg. 1951;15:286-299.
5. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based medicine guideline. Chest. 2000;118:1158-1171.
6. Davies RJO, Traill ZC, Gleeson FV. Randomized controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;525:416-421.
7. Bouros D, Schiza S, Pastourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic pleural effusions. Am J Respir Crit Care Med. 1997;155:291-295.
8. Defouilloy C, Meyer G, Slama M, et al. Intrapericardial fibrinolysis: a useful treatment in the management of purulent pericarditis. Intensive Care Med. 1997;23:117-118.
9. Maynar J, Corral E, Manzano A, et al. Intrapericardial streptokinase in the management of purulent pneumococcal pericarditis. Intensive Care Med. 1997;23:925-926.
10. Juneja R, Kothari SS, Saxena A, Sharma R, Joshi A. Intrapericardial streptokinase in purulent pericarditis. Arch Dis Child. 1999;80:275-277.
11. Bridgman PG. Failure of Intrapericardial streptokinase in purulent pericarditis. Intensive Care Med. 2001;27:942.
12. Mann-Segal DDM, Shanahan EA, Jones B, Ramasamy D. Purulent pericarditis: rediscovery of an old remedy. J Thorac Cardiovasc Surg. 1996;111:487-488.
13. http://www.fda.gov/cber/ltr/abbo12599.htm.
14. http://www.fda.gov/medwatch/safety/1999/strept.htm.